National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting, 49471 [2023-16135]

Download as PDF 49471 Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1 21 CFR section; activity Number of respondents Number of responses per respondent Total annual responses Average burden per response Total hours 100.1; petition for exemption from preemption .................... 1 1 1 40 40 1 There are no capital costs or operating and maintenance costs associated with this collection of information. The reporting burden for § 100.1 is minimal because petitions for exemption from preemption are seldom submitted by States. In the next 3 years, we estimate that one or fewer petitions will be submitted annually. Based on a review of the information collection since our last request for OMB approval, we have made no adjustments to our burden estimate. Dated: July 26, 2023. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2023–16151 Filed 7–28–23; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Amended Notice of Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, Opportunities for Collaborative Research at the NIH Clinical Center (U01), August 24, 2023, 2:00 p.m. to August 24, 2023, 4:00 p.m., National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD, 20892 which was published in the Federal Register on July 19, 2023, FR Doc 2023– 15228, 88 FRN 46172. The National Heart, Lung, and Blood Institute Special Emphasis Panel meeting is being amended due to a change of the meeting date and time formats. The meeting will be held on September 8, 2023, from 11:00 a.m. to 1:00 p.m. This meeting will be a videoassisted and closed to the public. Dated: July 25, 2023. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–16133 Filed 7–28–23; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:11 Jul 28, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Arthritis and Musculoskeletal and Skin Diseases Advisory Council. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend inperson or view the virtual meeting and need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https:// videocast.nih.gov/. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Arthritis and Musculoskeletal and Skin Diseases Advisory Council Date: August 29, 2023 Open: 9:00 a.m. to 1:00 p.m. Agenda: Discussion of Program Policies and Issues. Place: National Institutes of Health, Building 31, 6C Room A & B, 31 Center Drive, Bethesda, MD 20892 (Hybrid Meeting) Closed: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: National Institutes of Health, Building 31, 6C Room A & B, 31 Center Drive, Bethesda, MD 20892 Contact Person: Darren D. Sledjeski, Ph.D. Director, Division of Extramural Activities (DEA), National Institute of Arthritis and, Musculoskeletal and Skin Diseases, 6701 Democracy BLVD., Bethesda, MD 20892, (301) 451–7766, darren.sledjeski@nih.gov PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.niams.nih.gov/about/working-groups/ advisory-council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: July 25, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–16135 Filed 7–28–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which E:\FR\FM\31JYN1.SGM 31JYN1

Agencies

[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Page 49471]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16135]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Arthritis 
and Musculoskeletal and Skin Diseases Advisory Council.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend in-person or view the virtual meeting and need special 
assistance or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting. The meeting can 
be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Arthritis and Musculoskeletal and 
Skin Diseases Advisory Council
    Date: August 29, 2023
    Open: 9:00 a.m. to 1:00 p.m.
    Agenda: Discussion of Program Policies and Issues.
    Place: National Institutes of Health, Building 31, 6C Room A & 
B, 31 Center Drive, Bethesda, MD 20892 (Hybrid Meeting)
    Closed: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Building 31, 6C Room A & 
B, 31 Center Drive, Bethesda, MD 20892
    Contact Person: Darren D. Sledjeski, Ph.D. Director, Division of 
Extramural Activities (DEA), National Institute of Arthritis and, 
Musculoskeletal and Skin Diseases, 6701 Democracy BLVD., Bethesda, 
MD 20892, (301) 451-7766, [email protected]

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for 
entrance into on-campus and off-campus facilities. All visitor 
vehicles, including taxicabs, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors attending a 
meeting on campus or at an off-campus federal facility will be asked 
to show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit.
    Information is also available on the Institute's/Center's home 
page: https://www.niams.nih.gov/about/working-groups/advisory-council, where an agenda and any additional information for the 
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: July 25, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-16135 Filed 7-28-23; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.